On August 14, 2015, a motion for authority to sell assets of the estates pursuant to section 363 of the Bankruptcy Code was filed in the bankruptcy case of Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) and its affiliates.
The filing was assigned docket number 40 and is described on the court’s official docket as follows:
Motion to Approve /Debtor’s Motion for Order: (A) Approving Bid Procedures for the Sale of Substantially All of the Debtor’s Assets Outside the Ordinary Course of Business; (B) Scheduling an Auction and Hearing to Consider the Sale and Approve the Form and Manner of Notice Related Thereto; (C) Approving Payment of a Break-Up Fee; and (D) Granting Related Relief Filed by Response Genetics, Inc.. Hearing scheduled for 8/27/2015 at 10:30 AM at US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #2, Wilmington, Delaware. Objections due by 8/25/2015. (Attachments: # (1) Notice # (2) Exhibit A – Proposed Order with Annexes 1 through 7) (O’Neill, James)
Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on August 9, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-11663. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Pachulski Stang Ziehl & Jones LLP is acting as lead bankruptcy counsel to Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) in the bankruptcy case.